NEWS
OVER 40S URGED TO ACT OVER LUNG CANCER SYMPTOMS
NHS Lanarkshire is encouraging people who have tested negative for COVID-19, but who have a persistent new or different cough for three weeks or more, to seek medical advice.
National statistics, released as part of the Scottish Government’s Detect Cancer Early campaign, show around 25 per cent fewer lung cancers are being diagnosed now compared to pre-COVID-19.
NHS Lanarkshire has now highlighted that those aged 40 and over should not put off contacting their GP practice if they have any possible cancer symptoms.
For more information, signpost patients to
getcheckedearly.org.
NEW MEDICINES ACCEPTED
Medicines which can be used to treat a rare genetic disease in children and some cancer tumours with a genetic abnormality have been accepted by the Scottish Medicines Consortium (SMC) for use by NHSScotland.
Onasemnogene abeparvovec (Zolgensma) is a gene therapy for the treatment of spinal muscular atrophy (SMA): a very rare, muscle-wasting disease caused by a mutation in a gene that is critical to the function of the nerves that control muscles. The most severe form of the condition, SMA Type 1, is usually diagnosed in the first six months of an infant’s life.
Onasemnogene abeparvovec is given as a single intravenous infusion. It has the potential to significantly improve the length of life and may enable patients to develop motor skills which could lead to less disability over time. Entrecitinib (Rozlytrek) was accepted for the treatment of solid tumours (cancer growths) that have a rare genetic abnormality called NTRK gene fusion. It is a new type of medicine, sometimes called a tumour agnostic. These tumour agnostic medicines can be effective in tumours with specific genetic features, regardless of where the tumour is situated. Entrectinib is taken orally, and gives patients better symptom control.
NEW INITIATIVE HELPS PATIENTS SEE ‘DAYLIGHT’
A new digital therapy in the form of a mobile app is now available for people in Forth Valley, who are experiencing symptoms of worry and anxiety.
Known as Daylight, it uses science-backed cognitive behavioural techniques to guide patients through exercises to tackle anxiety and fears.
NHS and social care staff already have free access to Daylight and, in partnership with the Scottish Government, NHS Forth Valley is one of the first health boards in Scotland to extend this access to the public.
‘We are delighted to be able to offer Big Health’s cognitive behavioural therapy app Daylight free to people across Forth Valley,’ said Dr Sally Rankine, NHS Forth Valley’s Head of Adult Mental Health Psychology, ‘especially with the COVID-19 pandemic and lockdown leading to an increase in worry for many people.’
NEW LOOK SP MAG! 6
scottishpharmacist.com
Register to receive regular FREE ezines
scottishpharmacist.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
